An Interprofessional Collaborative Approach to Improve Oral Oncolytic Adherence

OncoLink Team
The Abramson Cancer Center of the University of Pennsylvania
Last Modified: May 11, 2015

Welcome to OncoLink's adherence education module for oncology professionals. This continuing education activity is designed to advance the education of oncology professionals regarding oral oncolytic adherence as well as improve the overall quality of life of cancer patients and their families by supporting their ability to adhere to prescribed treatments.

Watch the video below and then follow the instructions below the video box to obtain continuing education credits for nurses, social workers or pharmacists.

Download Slides [PDF]

Nursing Continuing Education Instructions

This continuing education activity is designed to advance the education of oncology professionals regarding oral oncolytic adherence as well as improve the overall quality of life of cancer patients and their families by supporting their ability to adhere to prescribed treatments.

This activity has been approved for 2.5 contact hours by the Hospital of the University of Pennsylvania, Department of Nursing Development and Education, an approved provider of continuing nursing education by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

The educational objectives of this activity are:

  • Define compliance, adherence and persistence to oral medications.
  • Demonstrate an understanding of the evolution of the terminology and its impact on patient centered care.
  • Describe various tools for improving adherence.
  • Explain the myths, benefits and risks of oral oncolytics.
  • Understand the impact of insurance/financial toxicity on access to medications and adherence.
  • Identify barriers to adherence for patients, healthcare professionals, and caregivers.
  • Explain intervention techniques to improve adherence and team collaboration/communication.

To receive continuing education credits for this activity:

  • Watch the presentation in its entirety.
  • Click on the link at the end to go to the posttest and complete the test.
  • If you do not achieve a passing score, you will return to the test and be able to retake the posttest.
  • If you achieve a score of 80% or higher, you can proceed to the evaluation form.
  • Once you submit the evaluation, the CE certificate will pop up. Please print this for your records. You will also receive a copy by email.

Conflicts of presenters or planning committee:

  • Carolyn Vachani, RN, MSN, Christina Bach, MBE, MSW, LCSW, OSW-C, and Donna Capozzi, PharmD, BOCP have no actual or potential financial or non-financial conflict of interests in relation to this presentation.
  • Elizabeth Prechtel Dunphy, MSN, CRNP, AOCN is a speaker for Bayer Healthcare Pharmaceuticals and Celgene Pharmaceuticals.

    This activity expires April 23, 2017.

Social Work Continuing Education Instructions

This continuing education activity is designed to advance the education of oncology professionals regarding oral oncolytic adherence as well as improve the overall quality of life of cancer patients and their families by supporting their ability to adhere to prescribed treatments.

The educational objectives of this activity are:

  • Define compliance, adherence and persistence to oral medications.
  • Demonstrate an understanding of the evolution of the terminology and its impact on patient centered care.
  • Describe various tools for improving adherence.
  • Explain the myths, benefits and risks of oral oncolytics.
  • Understand the impact of insurance/financial toxicity on access to medications and adherence.
  • Identify barriers to adherence for patients, healthcare professionals, and caregivers.
  • Explain intervention techniques to improve adherence and team collaboration/communication.

The Leukemia & Lymphoma Society, Provider # 1105, is approved as a provider for social work continuing education by the Association of Social Work Boards (www.aswb.org) through the Approved Continuing Education program. LLS maintains responsibility for the program. Social workers participating in this course will receive 2.0 CE clock hours. Licensed social workers should contact their individual jurisdictional board to review current continuing education requirements.

To receive continuing education credits for this activity:

  • Watch the presentation in its entirety.
  • Click on the link at the end to go to the posttest and complete the test.
  • If you do not achieve a passing score, you will return to the test and be able to retake the posttest.
  • If you achieve a score of 80% or higher, you can proceed to the evaluation form where you will need to enter your demographic information and SW license number.
  • CE certificates will be emailed.

Conflicts of presenters or planning committee:

  • Carolyn Vachani, RN, MSN, Christina Bach, MBE, MSW, LCSW, OSW-C, and Donna Capozzi, PharmD, BOCP have no actual or potential financial or non-financial conflict of interests in relation to this presentation.
  • Elizabeth Prechtel Dunphy, MSN, CRNP, AOCN is a speaker for Bayer Healthcare Pharmaceuticals and Celgene Pharmaceuticals.

This activity expires April 23, 2017.


Pharmacy Continuing Education Instructions

This continuing education activity is designed to advance the education of oncology professionals regarding oral oncolytic adherence as well as improve the overall quality of life of cancer patients and their families by supporting their ability to adhere to prescribed treatments.

The Nesbitt School of Pharmacy at Wilkes University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmaceutical education. Participants who attend the full program and complete an evaluation will be awarded a statement of credit at the conclusion of this program for 0.2CEU (2 contact hours). ACPE # 0097-9999-15-038-H05-P

The educational objectives of this activity are:

  • Define compliance, adherence and persistence to oral medications.
  • Demonstrate an understanding of the evolution of the terminology and its impact on patient centered care.
  • Describe various tools for improving adherence.
  • Explain the myths, benefits and risks of oral oncolytics.
  • Understand the impact of insurance/financial toxicity on access to medications and adherence.
  • Identify barriers to adherence for patients, healthcare professionals, and caregivers.
  • Explain intervention techniques to improve adherence and team collaboration/communication.

To receive pharmacy continuing education credits for this activity:

  • Watch the presentation in its entirety.
  • Click on the link at the end to go to the posttest and complete the test.
  • If you do not achieve a passing score, you will return to the test and be able to retake the posttest.
  • If you achieve a score of 80% or higher, you can proceed to the evaluation form.
  • Once you submit the evaluation, the CE certificate will pop up. Please print this for your records. You will also receive a copy by email.

Conflicts of presenters or planning committee:

  • Carolyn Vachani, RN, MSN, Christina Bach, MBE, MSW, LCSW, OSW-C, and Donna Capozzi, PharmD, BOCP have no actual or potential financial or non-financial conflict of interests in relation to this presentation.
  • Elizabeth Prechtel Dunphy, MSN, CRNP, AOCN is a speaker for Bayer Healthcare Pharmaceuticals and Celgene Pharmaceuticals.

This activity expires April 23, 2017.

PROCEED TO TEST »

Penn Medicine        LLS

This program is an interdisciplinary collaborative effort, including the team at OncoLink, The PENN Medicine Department of Pharmacy and The Leukemia and Lymphoma Society.

Keywords

Click on any of these terms for more related articles

Blogs

Thank You and You’re Welcome - Happy Nurses Week!
by Karen Arnold-Korzeniowski, BSN, RN
May 06, 2015

Cancer Center Advertising: Doing More Harm Than Good?
by Rodney Warner, JD
July 21, 2016